Exploratory Study of Personalized mRNA Vaccine in Patients With Refractory Rhabdomyosarcoma
NCT06932861
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
5
Enrollment
OTHER
Sponsor class
Conditions
Rhabdomyosarcoma
Interventions
BIOLOGICAL:
mRNA Tumor Vaccine Therapy
Sponsor
Xinxin Zhang